⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EWTX News
Edgewise Therapeutics, Inc. Common Stock
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
prnewswire.com
EWTX
Servier projette d'acquérir l'activité dystrophie musculaire d'Edgewise Therapeutics USA - Français USA - English USA - English
prnewswire.com
EWTX
Form 8-K
sec.gov
EWTX
Servier projette d'acquérir l'activité dystrophie musculaire d'Edgewise Therapeutics USA - Français USA - English USA - English
prnewswire.com
EWTX
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
prnewswire.com
EWTX
Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
prnewswire.com
EWTX
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business USA - English USA - Français USA - English
prnewswire.com
EWTX
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
globenewswire.com
ACHV
ORKA
EWTX
Form 8-K
sec.gov
EWTX
Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications
prnewswire.com
EWTX